Detection of KRAS,NRAS and BRAF gene mutations in colorectal carcinoma.
- Author:
Keping ZHANG
1
;
Jie XU
1
;
Lixu YAN
1
;
Xunhua LIU
1
;
Fangping XU
1
;
Yanhui LIU
2
;
E-mail: YANH_LIU@163.COM.
Author Information
- Publication Type:Journal Article
- MeSH: Base Sequence; Codon; Colorectal Neoplasms; genetics; DNA Mutational Analysis; Exons; Female; Genes, ras; Humans; Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; genetics; Sequence Analysis, DNA
- From: Chinese Journal of Pathology 2015;44(4):254-257
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate mutations frequencies of KRAS,NRAS and BRAF genes in colorectal carcinoma.
METHODSTissue specimens from 200 colorectal cancer patients at diagnosis were collected and subject to KRAS,NRAS and BRAF mutation analyses by PCR-based direct DNA sequencing targeting exons 2, 3 and 4 of KRAS gene, exons 2, 3 and 4 of NRAS gene and exon 15 of BRAF gene.
RESULTSActivating mutations were detected in KRAS (44%, 88/200), NRAS (2%, 4/200) and BRAF (5%, 10/200) in this study cohort.Among KRAS mutations, 64.8% (57/88) occurred in codon 12 and 12.5% (11/88) occurred in codon 13. KRAS gene mutation in exon 3 mainly involved codons 59 and 61. KRAS gene mutation in exon 4 mainly involved codons 117 and 146.
CONCLUSIONSMutations at exon 2 of KRAS gene have the highest frequency in colorectal carcinoma. Expanding the detection sites of KRAS gene combined with NRAS and BRAF genes may help to identify patients who will most likely benefit from targeted therapies.
